Actelion regularly offers the availability of Investor Relations personnel and senior management to the company’s investment clients. This includes presenting the company’s progress and opportunities for future growth at healthcare conferences, and visiting its clients to offer a better understanding of the company, its performance and its growth potential.

Where possible Actelion also welcomes institutional investors and sell-side analysts to its headquarters to experience the company's culture and view the established drug discovery capabilities.